| Announce Date | 10/29/2025 | 
| EPS Normalized Actual | $4.82 (Beat by $0.56) | 
| EPS GAAP Actual | $4.82 (Beat by $0.56) | 
| Revenue Actual | $3.215B | 
| Revenue Surprise | Beat by $3215M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $4.13813 | 
| EPS GAAP Estimate | $4.13813 | 
| Revenue Estimate | $3.314071649B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 33.49 | 27.44 | 32.74034 | 35.12945 | 1 | 
| Dec 2028 | 0 | INF | 0 | 0 | 4 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.86 | -1.65527 | 3.215B | 18.29% | 61.8M | 
| FQ1 2025 (Mar 2025) | 2.22 | 2.22 | 3.088B | 15.71% | 3088M | 
| FQ4 2024 (Dec 2024) | 1.86 | 1.86 | 2.957B | 17.59% | 2957M | 
| FQ3 2024 (Sep 2024) | 2.09 | 2.09 | 2.797B | 18.2% | 2797M | 
| FQ2 2024 (Jun 2024) | 1.27 | 1.27 | 2.627B | 18.16% | 2627M | 
| FQ1 2024 (Mar 2024) | 1.69 | 1.69 | 2.603B | 19.48% | 2603M | 
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 2.437B | 100% | 2437M | 
| FQ3 2023 (Sep 2023) | 1.18 | 1.18 | 2.288B | 100% | 2288M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
4.13813
Consensus Revenue Estimates
3.314071649B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.53991 | -- | 6.395 | 6.64256 | 18 | 
| FQ3 2027 (Sep 2027) | 6.16422 | -- | 6.11622 | 6.27208 | 19 | 
| FQ2 2027 (Jun 2027) | 5.28231 | -- | 5.24118 | 5.37474 | 10 | 
| FQ1 2027 (Mar 2027) | 5.47855 | -- | 5.43589 | 5.57442 | 13 | 
| FQ4 2026 (Oct 2026) | 4.99622 | -- | 4.87474 | 5.13245 | 8 | 
| FQ3 2026 (Jul 2026) | 4.26425 | -- | 4.16057 | 4.38052 | 9 | 
| FQ2 2026 (Jun 2026) | 4.3079 | 56.82 | 4.13733 | 4.41738 | 17 | 
| FQ1 2026 (Mar 2026) | 4.61127 | 51.86 | 4.42869 | 4.72846 | 8 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.87B | -- | 4.79B | 4.93B | 22 | 
| FQ3 2027 (Sep 2027) | 4.73B | -- | 4.7B | 4.79B | 20 | 
| FQ2 2027 (Jun 2027) | 4.43B | -- | 4.4B | 4.48B | 11 | 
| FQ1 2027 (Mar 2027) | 4.36B | -- | 4.34B | 4.42B | 14 | 
| FQ4 2026 (Oct 2026) | 3.95B | -- | 3.88B | 4.04B | 10 | 
| FQ3 2026 (Jul 2026) | 3.75B | -- | 3.68B | 3.83B | 10 | 
| FQ2 2026 (Jun 2026) | 3.77B | 14.66 | 3.65B | 3.84B | 10 | 
| FQ1 2026 (Mar 2026) | 3.72B | 17.02 | 3.61B | 3.79B | 10 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 3.51527 | 1.86 | -1.65527 | -88.99% | 
| FQ1 2025 (Mar 2025) | 2.22 | 2.22 | 100% | |
| FQ4 2024 (Dec 2024) | 1.86 | 1.86 | 100% | |
| FQ3 2024 (Sep 2024) | 2.09 | 2.09 | 100% | |
| FQ2 2024 (Jun 2024) | 1.27 | 1.27 | 100% | |
| FQ1 2024 (Mar 2024) | 1.69 | 1.69 | 100% | |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 100% | |
| FQ3 2023 (Sep 2023) | 1.18 | 1.18 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $3.15B | $3.22B | $61.8M | 1.92% | 
| FQ1 2025 (Mar 2025) | $0B | $3.09B | $3088M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $2.96B | $2957M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $2.8B | $2797M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $2.63B | $2627M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $2.6B | $2603M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $2.44B | $2437M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $2.29B | $2288M | 100% |